|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| C12M 1/00 | |||
| C12M 1/34 | |||
| G01N 33/50 | |||
| C12N 15/09 | |||
| G01N 33/68 |
| (11) | Patento numeris | 2505662 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10833015.0 |
| Europos patento paraiškos padavimo data | 2010-10-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-01-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2010/068909 |
| Data | 2010-10-26 |
| (87) | Numeris | WO 2011/065168 |
| Data | 2011-06-03 |
| (30) | Numeris | Data | Šalis |
| 2009266539 | 2009-11-24 | JP |
| (72) |
TSUZAKA, Kensei, JP
|
| (73) |
KayteeBio Co. & Ltd.,
VenturePlaza Funabashi No.110, 1-17-25, Kita-Honcho Funabashi-shi, Chiba 273-0864,
JP
|
| (54) | METHOD AND APPARATUS FOR PREDICTION OF PHARMACOLOGICAL EFFICACY OF HUMANIZED ANTI-TNF-alpha ANTIBODY DRUG ON RHEUMATOID ARTHRITIS |
| METHOD AND APPARATUS FOR PREDICTION OF PHARMACOLOGICAL EFFICACY OF HUMANIZED ANTI-TNF-alpha ANTIBODY DRUG ON RHEUMATOID ARTHRITIS |